Patent · US Active

3,3-spiroindolinone derivatives

US7553833B2 · kind B2 · utility

14Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 11, 2008
Grant dateJun 30, 2009
Priority date—
Expiry dateApr 11, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

There are provided compounds of the general formulaswherein X, Y, R1, R2, R3, R4 and R5 are as described herein. The compounds exhibit anticancer activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.